Full-Aspect CPOTB & Nano Technology: Why PT NHI is the Top Choice for FDI in the Herbal Sector

JAKARTA – The market for traditional medicine, health supplements, and herbal products across Southeast Asia continues to demonstrate rapid growth. Indonesia, rich in biodiversity and boasting a massive consumer market, has emerged as a primary destination for foreign investment. Amid rising interest in Foreign Direct Investment (FDI)—including from neighboring countries like Thailand—PT Nano Herbaltama Internasional (PT NHI) consolidates its position as a reliable, strategic local partner.

Two Primary Pillars Facilitating FDI with PT NHI

1. Fast-Track Market Entry: Starting a business from scratch in Indonesia often takes months or even years just to handle location permits, plant construction, and production standard certifications. Through an FDI partnership framework with PT NHI, foreign investors can streamline all these complexities:

• Utilization of Existing Facilities: Foreign investors do not need to build new manufacturing facilities from the ground up. PT NHI provides turn-key production facilities compliant with Full-Aspect CPOTB standards from BPOM, reinforced by advanced nanotechnology capabilities.
• Accelerated Time-to-Market: Leveraging an active infrastructure enables significantly faster product introductions and commercialization in the Indonesian market, dramatically lowering pre-operational expenditure.

2. Regulatory Guidance & Local Sales Permit Facilitation: Entering the traditional medicine and health supplement market as a Foreign Direct Investment requires strict compliance with the Indonesian Food and Drug Authority (BPOM) and the Halal Product Assurance Organizing Agency (BPJPH). PT NHI serves as a strategic bridge:

• Product Registration & Legality: Assisting and expediting product registration to secure BPOM Distribution Approval Numbers (NIE) alongside comprehensive Halal certification.
• Legal & Bureaucratic Risk Mitigation: Ensuring that all investment schemes and product operations align with the applicable legal framework for Foreign Direct Investment (FDI) and standard Indonesian Business Competition Classification (KBLI) guidelines.

Strategic Synergies for Regional Market Dominance: Through an FDI partnership model, collaboration between foreign investors and PT NHI focuses on joint product development (co-development), contract manufacturing (toll manufacturing/maklon), and the supply of high-tech raw materials. This approach empowers foreign companies to penetrate the Indonesian market quickly while utilizing Indonesia as an export production hub across the ASEAN region.

Requirements & Assistance Services for Herbal Sector FDI in Indonesia For foreign companies (such as prospective investors) seeking to establish operations and commit capital (FDI) in Indonesia’s herbal and supplement manufacturing sector, key regulatory requirements include:

1. Capital & Basic Legal Framework for FDI

• Minimum Investment: In accordance with BKPM/OSS RBA regulations, the minimum investment requirement for FDI (excluding land and buildings) is typically set at IDR 10 billion per KBLI code.
• Entity Structure: Must be established as a Foreign Direct Investment Limited Liability Company (PT PMA) in Indonesia.
• Paid-Up Capital: Minimum paid-up capital must comply with active BKPM provisions upon registration (generally governed under OSS regulations).

2. Corporate Administrative Documents

• Corporate Identity: Certificate of Incorporation / Articles of Association from the country of origin, legalized by the local Ministry of Foreign Affairs and the Embassy of the Republic of Indonesia (KBRI).
• Articles of Association: Investor company charter documents.
• Passports/Identity Cards: Identification for board directors and commissioner representatives.

3. Risk-Based Business Licensing (OSS RBA)

• Business Identification Number (NIB): Access clearance via the OSS system.
• Herbal/Manufacturing KBLI Code: Selecting appropriate KBLI classifications (e.g., KBLI for Traditional Medicine / Herbal Manufacturing Industry).
• Commercial & Operational Permits: Including environmental approvals (AMDAL/UKL-UPL) and spatial/location clearance.

4. Sector-Specific Health & Regulatory Standards (BPOM & Halal)

• CPOTB/GMP Certification: Mandatory ownership of or partnership with a factory holding Full-Aspect CPOTB certification (where PT NHI serves as an immediate plug-and-play local partner).
• BPOM Distribution Approval (NIE): Every commercialized product must undergo BPOM registration to acquire an official Distribution Approval Number.
• Halal Certification: Pursuant to statutory Halal assurance laws in Indonesia, traditional medicines and health supplements must comply with BPJPH regulatory standards.

Frequently Asked Questions (Q&A) Regarding FDI Collaboration & PT NHI

Q1: Why are foreign investors advised to partner with PT Nano Herbaltama Internasional (PT NHI) rather than building their own manufacturing facilities?

A: Constructing a new manufacturing plant from scratch takes years of land permitting, spatial approval, physical construction, and BPOM certification. Partnering with PT NHI provides a fast-track solution. PT NHI offers turn-key manufacturing infrastructure certified under Full-Aspect CPOTB and powered by nanotechnology, enabling investors to transition directly into production and commercialization efficiently.

Q2: What is PT NHI’s track record and industry experience in the Indonesian market?

A: PT NHI brings over 15 years of industry experience in manufacturing and product development across Indonesia’s health sector. Over more than a decade, PT NHI has gained deep insights into local market dynamics, trends, and consumer behavior, enabling us to provide strategic guidance so foreign investors can achieve strong product acceptance.

Q3: Which industrial sectors represent PT NHI’s core strengths and ecosystem reach?

A: PT NHI operates a broad and integrated business ecosystem across three main sectors:

• Herbal / Traditional Medicine Industry: High-standard processing of natural extracts.
• Cosmetics & Skincare Industry: Modern skincare formulations utilizing natural active ingredients.
• Health Supplement Industry: Development of high-nutrition functional foods and supplements. This network covers raw material supply chains, academic research alliances, and B2B distribution channels.

Q4: What technological advantages does PT NHI bring to FDI partnerships?

A: PT NHI is a pioneer in applying nanotechnology to natural active ingredients (such as nao propolis, nano chitosan, and nano albumin extracts, etc). This technology reduces active particle sizes to the nano-scale, significantly improving absorption (bioavailability), efficacy, and product differentiation (unique selling points) needed to compete in the ASEAN market.

Q5: How does PT NHI assist foreign investors with product licensing and legal approvals?

A: PT NHI provides end-to-end support ranging from BPOM Distribution Approval Number (NIE) registration and Halal certification (BPJPH) processing to fulfilling foreign investment regulatory requirements under KBLI standards. PT NHI’s experienced internal team ensures all operational and legal aspects strictly align with Indonesian law.

Q6: What is the minimum investment value and primary legal requirement for operating under an FDI model in Indonesia?

A: Pursuant to BKPM (OSS RBA) rules in Indonesia, foundational requirements for an FDI framework include:

• Minimum Investment Value: Generally set at a minimum of IDR 10 billion (excluding land and buildings) per KBLI code.
• Corporate Entity: Must be incorporated as a Foreign Direct Investment Company (PT PMA).
• Administrative Requirements: Submitting a Certificate of Incorporation (legalized by KBRI), Corporate Charter/Articles of Association, and identity credentials for Board Directors and Commissioners.

Conclusion:

Connecting Foreign Investment with the Local Ecosystem. PT Nano Herbaltama Internasional serves as a full-aspect CPOTB-certified and nanotechnology-driven local partner, addressing foreign investor concerns regarding regulatory readiness, production capacity, and advanced technology. Through well-aligned synergies, an FDI partnership delivers strong commercial returns for both parties while reinforcing Indonesia’s standing as a trusted hub for herbal innovation in Southeast Asia.